SCHEMBL4879312

SCHEMBL4879312

COc1cccc([C@]2(NS(C)(=O)=O)CC[C@@H](NCc3ccc(-c4ccccc4)cc3)CC2)c1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.45
MEN1 O00255 2/20 0.44
KMT2A Q03164 2/20 0.44
RAB9A P51151 1/20 0.44
MMP1 P03956 2/20 0.42
MMP2 P08253 2/20 0.42
MMP3 P08254 2/20 0.42
MMP13 P45452 2/20 0.42
OPRM1 P35372 2/20 0.42
OPRL1 P41146 2/20 0.42
FAAH O00519 1/20 0.39
NAAA Q02083 1/20 0.39
HDAC1 Q13547 2/20 0.37
SCN9A Q15858 1/20 0.37
KDM1A O60341 2/20 0.37
FABP6 P51161 1/20 0.37
TAS2R14 Q9NYV8 1/20 0.37
MAOA P21397 1/20 0.37
MAOB P27338 1/20 0.37
NPY1R P25929 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4879320 1.00 ALDH1A1 (0.45) ALDH1A1MEN1KMT2ARAB9AMMP1
SCHEMBL4880418 0.91 ALDH1A1 (0.44) ALDH1A1MEN1KMT2ARAB9AMMP1
SCHEMBL4880409 0.91 ALDH1A1 (0.44) ALDH1A1MEN1KMT2ARAB9AMMP1
SCHEMBL4874770 0.85 ALDH1A1 (0.43) ALDH1A1MEN1KMT2ARAB9AMMP1
SCHEMBL4874777 0.85 ALDH1A1 (0.43) ALDH1A1MEN1KMT2ARAB9AMMP1
SCHEMBL5477616 0.81 ALDH1A1 (0.47) ALDH1A1MEN1KMT2ARAB9AMMP1
SCHEMBL5477620 0.81 ALDH1A1 (0.47) ALDH1A1MEN1KMT2ARAB9AMMP1
SCHEMBL14194850 0.80 ALDH1A1 (0.43) ALDH1A1MEN1KMT2ARAB9AMMP1
SCHEMBL14194851 0.80 ALDH1A1 (0.43) ALDH1A1MEN1KMT2ARAB9AMMP1
SCHEMBL4878765 0.80 KMT2A (0.51) ALDH1A1MEN1KMT2ARAB9AOPRM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080096922-A1 Novel Sulfonamide derivative DAINIPPON SUMITOMO PHARMA CO., LTD. (JP) 2008-04-24 US disclosed
EP-1736467-A1 NOVEL SULFONAMIDE DERIVATIVE Dainippon Sumitomo Pharma Co., Ltd. (JP) 2006-12-27 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080096922-A1 Novel Sulfonamide derivative NR4A1, NR4A2, NR4A3 ALDH1A1 2899/4885MEN1 3740/4885KMT2A 1132/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.